279 related articles for article (PubMed ID: 31375988)
21. Factors influencing serum neurofilament light chain levels in normal aging.
Koini M; Pirpamer L; Hofer E; Buchmann A; Pinter D; Ropele S; Enzinger C; Benkert P; Leppert D; Kuhle J; Schmidt R; Khalil M
Aging (Albany NY); 2021 Dec; 13(24):25729-25738. PubMed ID: 34923481
[TBL] [Abstract][Full Text] [Related]
22. Serum neurofilament light chain in chronic inflammatory demyelinating polyneuropathy.
van Lieverloo GGA; Wieske L; Verhamme C; Vrancken AFJ; van Doorn PA; Michalak Z; Barro C; van Schaik IN; Kuhle J; Eftimov F
J Peripher Nerv Syst; 2019 Jun; 24(2):187-194. PubMed ID: 30973667
[TBL] [Abstract][Full Text] [Related]
23. Serum neurofilament light chain levels associations with gray matter pathology: a 5-year longitudinal study.
Jakimovski D; Kuhle J; Ramanathan M; Barro C; Tomic D; Hagemeier J; Kropshofer H; Bergsland N; Leppert D; Dwyer MG; Michalak Z; Benedict RHB; Weinstock-Guttman B; Zivadinov R
Ann Clin Transl Neurol; 2019 Sep; 6(9):1757-1770. PubMed ID: 31437387
[TBL] [Abstract][Full Text] [Related]
24. Neuroprotective associations of apolipoproteins A-I and A-II with neurofilament levels in early multiple sclerosis.
McComb M; Krikheli M; Uher T; Browne RW; Srpova B; Oechtering J; Maceski AM; Tyblova M; Jakimovski D; Ramasamy DP; Bergsland N; Krasensky J; Noskova L; Fialova L; Weinstock-Guttman B; Havrdova EK; Vaneckova M; Zivadinov R; Horakova D; Kuhle J; Ramanathan M
J Clin Lipidol; 2020; 14(5):675-684.e2. PubMed ID: 32758395
[TBL] [Abstract][Full Text] [Related]
25. Serum neurofilament levels and patient-reported outcomes in multiple sclerosis.
Galetta K; Deshpande C; Healy BC; Glanz B; Ziehn M; Saxena S; Paul A; Saleh F; Collins M; Gaitan-Walsh P; Castro-Mendoza P; Weiner HL; Chitnis T
Ann Clin Transl Neurol; 2021 Mar; 8(3):631-638. PubMed ID: 33492760
[TBL] [Abstract][Full Text] [Related]
26. Association of serum neurofilament light and disease severity in patients with spinocerebellar ataxia type 3.
Peng Y; Zhang Y; Chen Z; Peng H; Wan N; Zhang J; Tang J; Wang P; Xie Y; Cai Q; Liu S; Zhang X; Wang C; Yuan H; Li T; Wan L; Shi Y; Qiu R; Klockgether T; Tang B; Liao W; Jiang H
Neurology; 2020 Dec; 95(22):e2977-e2987. PubMed ID: 32817181
[TBL] [Abstract][Full Text] [Related]
27. Serum uric acid and outcome after acute ischemic stroke: PREMIER study.
Chiquete E; Ruiz-Sandoval JL; Murillo-Bonilla LM; Arauz A; Orozco-Valera DR; Ochoa-Guzmán A; Villarreal-Careaga J; León-Jiménez C; Barinagarrementeria F; Ramos-Moreno A; Cantú-Brito C
Cerebrovasc Dis; 2013; 35(2):168-74. PubMed ID: 23446426
[TBL] [Abstract][Full Text] [Related]
28. Incremental value of serum neurofilament light chain and glial fibrillary acidic protein as blood-based biomarkers for predicting functional outcome in severe acute ischemic stroke.
Vollmuth C; Fiessler C; Montellano FA; Kollikowski AM; Essig F; Oeckl P; Barba L; Steinacker P; Schulz C; Ungethüm K; Wolf J; Pham M; Schuhmann MK; Heuschmann PU; Haeusler KG; Stoll G; Otto M; Neugebauer H
Eur Stroke J; 2024 Feb; ():23969873241234436. PubMed ID: 38400734
[TBL] [Abstract][Full Text] [Related]
29. Profiling individual clinical responses by high-frequency serum neurofilament assessment in MS.
Akgün K; Kretschmann N; Haase R; Proschmann U; Kitzler HH; Reichmann H; Ziemssen T
Neurol Neuroimmunol Neuroinflamm; 2019 May; 6(3):e555. PubMed ID: 31119188
[TBL] [Abstract][Full Text] [Related]
30. Altered levels of circulating insulin-like growth factor I (IGF-I) following ischemic stroke are associated with outcome - a prospective observational study.
Åberg ND; Åberg D; Jood K; Nilsson M; Blomstrand C; Kuhn HG; Svensson J; Jern C; Isgaard J
BMC Neurol; 2018 Aug; 18(1):106. PubMed ID: 30081862
[TBL] [Abstract][Full Text] [Related]
31. Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort study.
Bittner S; Steffen F; Uphaus T; Muthuraman M; Fleischer V; Salmen A; Luessi F; Berthele A; Klotz L; Meuth SG; Bayas A; Paul F; Hartung HP; Linker R; Heesen C; Stangel M; Wildemann B; Then Bergh F; Tackenberg B; Kuempfel T; Weber F; Zettl UK; Ziemann U; Tumani H; Groppa S; Mühlau M; Lukas C; Hemmer B; Wiendl H; Gold R; Zipp F;
EBioMedicine; 2020 Jun; 56():102807. PubMed ID: 32460167
[TBL] [Abstract][Full Text] [Related]
32. Combination of Serum Neurofilament Light Chain Levels and MRI Markers to Predict Cognitive Function in Ischemic Stroke.
Peng Y; Li Q; Qin L; He Y; Luo X; Lan Y; Chen X; Wang X; Wang QM
Neurorehabil Neural Repair; 2021 Mar; 35(3):247-255. PubMed ID: 33522401
[TBL] [Abstract][Full Text] [Related]
33. Low free triiodothyronine predicts poor functional outcome after acute ischemic stroke.
Suda S; Muraga K; Kanamaru T; Okubo S; Abe A; Aoki J; Suzuki K; Sakamoto Y; Shimoyama T; Nito C; Kimura K
J Neurol Sci; 2016 Sep; 368():89-93. PubMed ID: 27538607
[TBL] [Abstract][Full Text] [Related]
34. Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosis.
Reinert MC; Benkert P; Wuerfel J; Michalak Z; Ruberte E; Barro C; Huppke P; Stark W; Kropshofer H; Tomic D; Leppert D; Kuhle J; Brück W; Gärtner J
Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32404429
[TBL] [Abstract][Full Text] [Related]
35. Serum neurofilament light chain is a discriminative biomarker between frontotemporal lobar degeneration and primary psychiatric disorders.
Katisko K; Cajanus A; Jääskeläinen O; Kontkanen A; Hartikainen P; Korhonen VE; Helisalmi S; Haapasalo A; Koivumaa-Honkanen H; Herukka SK; Remes AM; Solje E
J Neurol; 2020 Jan; 267(1):162-167. PubMed ID: 31595378
[TBL] [Abstract][Full Text] [Related]
36. Elevated serum neurofilament light chain in children autism spectrum disorder: A case control study.
He WC; Zhang XJ; Zhang YQ; Zhang WJ
Neurotoxicology; 2020 Sep; 80():87-92. PubMed ID: 32592719
[TBL] [Abstract][Full Text] [Related]
37. Serum β-synuclein, neurofilament light chain and glial fibrillary acidic protein as prognostic biomarkers in moderate-to-severe acute ischemic stroke.
Barba L; Vollmuth C; Abu-Rumeileh S; Halbgebauer S; Oeckl P; Steinacker P; Kollikowski AM; Schultz C; Wolf J; Pham M; Schuhmann MK; Heuschmann PU; Haeusler KG; Stoll G; Neugebauer H; Otto M
Sci Rep; 2023 Nov; 13(1):20941. PubMed ID: 38017278
[TBL] [Abstract][Full Text] [Related]
38. Neurofilament Light Chain Levels in Anti-NMDAR Encephalitis and Primary Psychiatric Psychosis.
Guasp M; Martín-Aguilar L; Sabater L; Bioque M; Armangué T; Martínez-Hernández E; Landa J; Maudes E; Borràs R; Muñoz-Lopetegi A; Saiz A; Castro-Fornieles J; Graus F; Parellada E; Querol L; Dalmau J
Neurology; 2022 Apr; 98(14):e1489-e1498. PubMed ID: 35145006
[TBL] [Abstract][Full Text] [Related]
39. Temporal association of sNfL and gad-enhancing lesions in multiple sclerosis.
Rosso M; Gonzalez CT; Healy BC; Saxena S; Paul A; Bjornevik K; Kuhle J; Benkert P; Leppert D; Guttmann C; Bakshi R; Weiner HL; Chitnis T
Ann Clin Transl Neurol; 2020 Jun; 7(6):945-955. PubMed ID: 32452160
[TBL] [Abstract][Full Text] [Related]
40. Circulating levels of vascular endothelial growth factor and post-stroke long-term functional outcome.
Åberg ND; Wall A; Anger O; Jood K; Andreasson U; Blennow K; Zetterberg H; Isgaard J; Jern C; Svensson J
Acta Neurol Scand; 2020 May; 141(5):405-414. PubMed ID: 31919840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
